There are several reasons why drug prices are higher in the U.S. than in Canada. The main factors are as follows:

Differences in Government Price Regulation

  • U.S.: In the U.S., pharmaceutical companies can freely set the prices of their drugs. Since the government does not impose direct price controls, companies set prices based on market conditions.

  • Canada: In contrast, Canada strictly regulates drug prices through government oversight. Agencies like the 'Patented Medicine Prices Review Board (PMPRB)' review drug prices and control them to maintain reasonable levels.

Price Negotiation and Insurance Systems

  • U.S.: The U.S. healthcare insurance system is led by private insurers, which are relatively weak in negotiations with pharmaceutical companies. Public insurance programs like Medicare also have limitations in price negotiations, allowing high drug prices to persist.

  • Canada: Canada conducts strong price negotiations with pharmaceutical companies based on bulk purchasing through a single public healthcare system, effectively lowering drug prices.

Research and Development (R&D) Costs and Marketing

  • U.S.: Pharmaceutical companies claim that the high drug prices in the U.S. are invested in recovering R&D costs and developing new drugs. However, significant expenses are actually spent on marketing and executive compensation, maintaining high profit margins.

  • Canada: Canadian pharmaceutical companies operate efficiently with relatively low drug prices through effective R&D and marketing strategies.

Patents and Generic Drugs

  • U.S.: During the patent protection period, pharmaceutical companies sell drugs exclusively and maintain high prices. Additionally, delays in the release of generic drugs mean consumers bear high drug costs for extended periods.

  • Canada: Canada contributes to lowering drug prices through the rapid introduction of generic drugs.

5. Market Size and Economic Power

  • U.S.: The U.S. has a massive market size and high economic power, allowing pharmaceutical companies to set high prices that consumers can afford.

  • Canada: Canada has a relatively small market size and ensures access to medications for its citizens through government price controls.

Due to these factors, drug prices in the U.S. are higher than in Canada. Recently, various policies and discussions have been initiated in the U.S. to lower drug prices, but significant changes are unlikely in the short term due to fundamental system differences.